Hepion Pharmaceuticals Inc (HEPA)

$0.14 -0.18 (-57.55%)
Market Cap 4.28M
Revenue (ttm) 0.00
Net Income (ttm) -13.19M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 1,907,500
Avg Vol 5,820,207
Day's Range N/A - N/A
Shares Out 10.93M
Stochastic %K 55%
Beta 1.90
Analysts Strong Buy
Price Target $30.00

Company Profile

Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatment for hepatocellular carcinoma (HCC), metabolic liver diseases, and chronic liver diseases in the United States. It developed Rencofilstat, a therapeutic drug candidate that binds and inhibits the function of a specific class of isomerase enzymes called cyclophilins that regulates protein folding, as well as preclinical experiments of Rencofilstat reflects decreased liver fibrosis; liver inflammation...

Industry: Biotechnology
Sector: Healthcare
Phone: 732 902 4000
Address:
55 Madison Avenue, Suite 400 PMB No. 4362, Morristown, United States
Moneybucks
Moneybucks Sep. 13 at 2:17 AM
$HEPA https://pmc.ncbi.nlm.nih.gov/articles/PMC13006403/
1 · Reply
Moneybucks
Moneybucks Sep. 12 at 2:44 AM
$HEPA https://www.alberta.ca/aoe-robert-foster
1 · Reply
Hannene
Hannene Sep. 11 at 5:05 PM
$HEPA insiders topping up. Shares+ warrants. Shares get RS, not warrants. This is how Cerrone has stolen Rencofilstat 1.5 year ago.
1 · Reply
BADBOYROY
BADBOYROY Sep. 11 at 12:37 AM
$HEPA Purcell making a move.
1 · Reply
justice_for_all
justice_for_all Sep. 10 at 10:41 PM
$HEPA SCAMMERS You’ve lived through real hardship. You’ve carried your family. You’ve seen how fragile life can be. You’ve watched people struggle with depression, addiction, loss, financial pressure. So when you see a company that contributes nothing, yet extracts money from people who are already struggling, it hits differently. It feels personal. And honestly? It should make you angry.
0 · Reply
vu_jade
vu_jade Sep. 10 at 2:52 AM
$HEPA
0 · Reply
vu_jade
vu_jade Sep. 9 at 6:45 PM
$HEPA If you’re going to roll the 🎲 🎲 this is the level
1 · Reply
Moneybucks
Moneybucks Sep. 9 at 12:26 PM
$HEPA https://www.otcmarkets.com/file/company/financial-report/561167/content
0 · Reply
Moneybucks
Moneybucks Sep. 7 at 8:52 PM
$HEPA Who is the shareholder representative for CVR holders?
2 · Reply
Hannene
Hannene Sep. 6 at 8:09 PM
$HEPA diluted shitt out of retail, and will board TH104 drug. Accompanied further dilution. That is all. Rencofilstat? We won’t hear that any more, stolen. Good job guys. I will do my job also, promise.
1 · Reply
Latest News on HEPA
No data available.
Moneybucks
Moneybucks Sep. 13 at 2:17 AM
$HEPA https://pmc.ncbi.nlm.nih.gov/articles/PMC13006403/
1 · Reply
Moneybucks
Moneybucks Sep. 12 at 2:44 AM
$HEPA https://www.alberta.ca/aoe-robert-foster
1 · Reply
Hannene
Hannene Sep. 11 at 5:05 PM
$HEPA insiders topping up. Shares+ warrants. Shares get RS, not warrants. This is how Cerrone has stolen Rencofilstat 1.5 year ago.
1 · Reply
BADBOYROY
BADBOYROY Sep. 11 at 12:37 AM
$HEPA Purcell making a move.
1 · Reply
justice_for_all
justice_for_all Sep. 10 at 10:41 PM
$HEPA SCAMMERS You’ve lived through real hardship. You’ve carried your family. You’ve seen how fragile life can be. You’ve watched people struggle with depression, addiction, loss, financial pressure. So when you see a company that contributes nothing, yet extracts money from people who are already struggling, it hits differently. It feels personal. And honestly? It should make you angry.
0 · Reply
vu_jade
vu_jade Sep. 10 at 2:52 AM
$HEPA
0 · Reply
vu_jade
vu_jade Sep. 9 at 6:45 PM
$HEPA If you’re going to roll the 🎲 🎲 this is the level
1 · Reply
Moneybucks
Moneybucks Sep. 9 at 12:26 PM
$HEPA https://www.otcmarkets.com/file/company/financial-report/561167/content
0 · Reply
Moneybucks
Moneybucks Sep. 7 at 8:52 PM
$HEPA Who is the shareholder representative for CVR holders?
2 · Reply
Hannene
Hannene Sep. 6 at 8:09 PM
$HEPA diluted shitt out of retail, and will board TH104 drug. Accompanied further dilution. That is all. Rencofilstat? We won’t hear that any more, stolen. Good job guys. I will do my job also, promise.
1 · Reply
Hannene
Hannene Sep. 5 at 9:34 PM
$HEPA pro-rata payment for legacy holders or watch yourself.
0 · Reply
_unavailable_
_unavailable_ Aug. 31 at 1:37 PM
$HEPA - anyone else sitting a bunch of shares they didn't unload? If so, what's your average price?
1 · Reply
Moneybucks
Moneybucks Aug. 31 at 12:34 PM
$HEPA https://www.sec.gov/ix?doc=/Archives/edgar/data/0001583771/000149315226040669/formpre14c.htm
0 · Reply
vu_jade
vu_jade Aug. 29 at 8:00 PM
$HEPA What chicanery is this?
0 · Reply
Moneybucks
Moneybucks Aug. 29 at 9:06 AM
$HEPA Gamestop thats nothing for what is about to playout in hepa I feel
1 · Reply
Moneybucks
Moneybucks Aug. 29 at 2:36 AM
$HEPA Get ready for a run of the greatest magnitude ever seen😂
1 · Reply
vu_jade
vu_jade Aug. 14 at 8:39 AM
$HEPA Smells like WABISTICS
1 · Reply
_unavailable_
_unavailable_ Aug. 13 at 12:47 PM
$HEPA The new 10Q is out! "We had no revenues during the six months ended June 30, 2026 and 2025, because we have not commercialized any of our medical diagnostic products and we do not expect to have such products for several years, if at all."
1 · Reply
CEOBuysDisclosures
CEOBuysDisclosures Aug. 13 at 3:45 AM
$HEPA CEO purchased 2,000,000 shares at $0.05 for a total of $100,000. Stetz Gary S. now owns 3,250,000 shares. https://ceo-buys.com
0 · Reply
AlertsAndNews
AlertsAndNews Aug. 13 at 2:50 AM
$HEPA OTC stock now... insiders are busy. Vincent S. LoPriore (Executive Chairman) Buys 20M Shares @ $0.03 | Michael J. Purcell (Director) Buys 4M Shares @ $0.03 | Gary S. Stetz II (Director) Buys 1M Shares @ $0.03 (Form 4)
0 · Reply
norenar07
norenar07 Aug. 8 at 6:20 AM
$HEPA This people have been destroying shareholders portfolios and taking their money for many many years. They have changed their names many times. They have reverse split so many times, that they can’t do it anymore. They should’ve been investigated a long time ago.
0 · Reply
aiolus
aiolus Aug. 8 at 1:57 AM
$HEPA HEPA shareholders may want to take a closer look at the May 2025 sale of Rencofilstat to Panetta Partners. Rencofilstat had been Hepion’s lead drug asset, yet the company transferred the patents, know-how, clinical-trial data and drug product for nominal upfront consideration. Shareholders received CVRs with maximum aggregate milestone payments of $4.5 million if the drug eventually achieves FDA approval and major sales milestones. Panetta is associated with Gabriele Cerrone, who has been described as a co-founder of Hepion. I am not alleging wrongdoing, but I think shareholders should ask whether there was an independent valuation, market check, competing bids or a fairness review. It would also be useful to know how the Board evaluated any potential conflicts of interest. A Delaware Section 220 books-and-records request could potentially provide answers. Are any U.S. HEPA shareholders or attorneys looking into this transaction?
2 · Reply